Skip to main content

Leading the Way: Approaches in Biomarker Testing for HRD

A Standardized Approach

Intro

Welcome to Leading the Way

Chapter 1

Become a Testing Champion

Chapter 2

Gain Consensus on the Need to Standardize

Chapter 3

Design a Standard Protocol

Chapters

More from this 3-part series

Forming the Oncology Committee
With Robert Neff, MD, and Courtney Rice, MS, LCGC

Importance of Pilot Efforts
With Dana Clark, MS, LCGC

Program Objectives

Discuss how to build relationships and provide educational support to your colleagues.

Gain insight on how to build a consensus on standardized testing for homologous recombination deficiency (HRD) in patients with advanced ovarian cancer.

Explore one institution’s step‑by‑step process for creating a standardized approach.

Clinical Perspectives
Presented by:

Dr Shiller

S. Michelle Shiller, DO, AP/CP, MGP

Medical Director of Genomics and Molecular Pathology
Chair of the Quality Committee

All HCPs were compensated for their participation in this program.

 

For educational purposes only. Tips and strategies discussed are based on the experiences of individual healthcare providers and their institutions and are not meant to represent universal standards in HRD testing. There is no guarantee that these strategies will work for all institutions.